マーケットレポート詳細

In Vitro毒性試験の世界市場:製品別、試験別2027年予測

In Vitro Toxicology Testing Market by Product (Assays (Western Blot, Tissue Culture), Equipment, Consumables, Software), Toxicity Endpoints (ADME, Skin Irritation, Cytotoxicity), Technology, Method, Industry (Pharma,Biotech) - Global Forecast to 2027

出版元:MarketsandMarkets   出版元について
発行年:2022年6月
定価 :Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算(お見積り日TTSレート)となります。
納品形態:PDF by Email
当調査レポートは英文356ページになります。
商品コード:MAM2953

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。

【レポート紹介】

In Vitro毒性試験の世界市場規模は2022年で112億ドル、2027年に186億ドル、市場の平均年成長率は10.8%になると当レポートは予測しています。
レポートはボIn Vitro毒性試験の世界市場について2027年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測(製品/サービス別市場、技術別市場、等)を中心に構成されています。また競合状況、主要企業情報(12社)、ファイブフォース分析、市場シェア分析などの分析も加味し、In Vitro毒性試験市場の動向および今後成長性を詳細にレポートしています。

【レポート構成概要】

◆In Vitro毒性試験の世界市場予測2019-2027年

・市場規模(US$)

◆製品/サービス別、市場-2027年

消耗品
アッセイ
・細菌毒性アッセイ
・酵素毒性アッセイ
・セルベースELISA/ウエスタンブロッティング
・受容体結合アッセイ
・組織培養アッセイ
・その他アッセイ
装置
ソフトウェア
サービス
※(市場規模US$)

◆毒性エンドポイント/試験別、市場-2027年

・ADME(吸収/分布/代謝/排泄)試験
・皮膚刺激性/腐食性/感作性試験
・遺伝毒性試験
・細胞毒性試験
・眼毒性試験
・臓器毒性試験
・光毒性試験
・皮膚毒性試験
・その他毒性エンドポイント/試験
※(市場規模US$)

◆技術別、市場-2027年

・細胞培養
・ハイスループット
・トキシコゲノミクス
※(市場規模US$)

◆産業別、市場-2027年

・製薬/バイオ医薬品
・化粧品/家庭用品
・食品
・化学薬品
※(市場規模US$)

◆メソッド別、市場-2027年

・細胞アッセイ
・生化学アッセイ
・In silicoモデル
・Ex vivoモデル
※(市場規模US$)

◆主要国地域別市場-2027年

欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
北米
・米国、カナダ
アジア太平洋
・日本、中国、インド
・その他アジア太平洋
中南米
中東アフリカ
※国地域別に全セグメント別の細分化データ掲載、詳細は目次参照

◆市場分析

・市場ダイナミクス(ドライバー、障壁、機会、課題)
・産業トレンド
・サプライチェーン分析
・COVID-19の影響
・ファイブフォース分析
・技術分析
・市場シェア分析
・競合状況

◆In Vitro毒性試験の主要企業プロフィール動向

・THERMO FISHER SCIENTIFIC, INC.
・MERCK KGAA
・EUROFINS SCIENTIFIC SE
・GENERAL ELECTRIC COMPANY
・LABORATORY CORPORATION OF AMERICA HOLDINGS
・CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
・SGS SA
・BIO-RAD LABORATORIES, INC.
・QIAGEN
・EVOTEC AG
・PROMEGA CORPORATION
・CATALENT, INC.

(その他企業)
・GENTRONIX LIMITED
・MB RESEARCH LABORATORIES
・BIOIVT
・CREATIVE BIOLABS
・GVK BIOSCIENCES PRIVATE LIMITED
・SHANGHAI MEDICILON INC.
・CREATIVE BIOARRAY
・INSPHERO

(全356頁)


【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

Table of Contents (英文詳細目次)

1      INTRODUCTION

1.1             STUDY OBJECTIVES
1.2             MARKET DEFINITION
1.2.1              INCLUSIONS AND EXCLUSIONS
1.2.2              MARKETS COVERED   45
・     FIGURE 1            IN VITRO TOXICOLOGY TESTING MARKET
・     FIGURE 2            IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC SCOPE
1.2.3              YEARS CONSIDERED FOR STUDY
1.3             CURRENCY
1.4             STAKEHOLDERS
1.5             LIMITATIONS
1.6             SUMMARY OF CHANGES

2      RESEARCH METHODOLOGY

2.1             RESEARCH APPROACH
・     FIGURE 3            RESEARCH DESIGN   49
2.1.1              SECONDARY RESEARCH
2.1.1.1            KEY DATA FROM SECONDARY SOURCES
2.1.2              PRIMARY RESEARCH   51
2.1.2.1            KEY DATA FROM PRIMARY SOURCES
2.1.2.2            BREAKDOWN OF PRIMARIES
・     FIGURE 4            BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2             MARKET SIZE ESTIMATION & VALIDATION APPROACH
・     FIGURE 5            MARKET SIZE APPROACH
・     FIGURE 6            BOTTOM-UP APPROACH
2.3             DATA TRIANGULATION APPROACH
・     FIGURE 7            DATA TRIANGULATION METHODOLOGY
2.4             MARKET SHARE ESTIMATION
2.5             ASSUMPTIONS FOR STUDY

3      EXECUTIVE SUMMARY

・     FIGURE 8            IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE,
2022 VS. 2027 (USD MILLION)
・     FIGURE 9            IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT &
TEST, 2022 VS. 2027 (USD MILLION)
・     FIGURE 10          IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022 VS. 2027 (USD MILLION)
・     FIGURE 11          IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022 VS. 2027 (USD MILLION)
・     FIGURE 12          IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022 VS. 2027 (USD MILLION)
・     FIGURE 13          GEOGRAPHIC ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET

4      PREMIUM INSIGHTS

4.1             IN VITRO TOXICOLOGY TESTING MARKET OVERVIEW
・     FIGURE 14          OPPOSITION TO ANIMAL TESTING IS MAJOR FACTOR
DRIVING MARKET GROWTH
4.2             ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD
・     FIGURE 15          CELLULAR ASSAYS HELD LARGEST SHARE OF IN VITRO TOXICOLOGY TESTING MARKET IN ASIA PACIFIC IN 2021
4.3             IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・     FIGURE 16          CHINA IS LIKELY TO BE FASTEST-GROWING MARKET IN GLOBAL IN VITRO TOXICOLOGY TESTING MARKET DURING FORECAST PERIOD
4.4             IN VITRO TOXICOLOGY TESTING MARKET, BY REGION
・     FIGURE 17          EUROPE WILL CONTINUE TO DOMINATE IN VITRO TOXICOLOGY TESTING MARKET IN 2027
4.5             IN VITRO TOXICOLOGY TESTING MARKET: DEVELOPED VS. DEVELOPING MARKETS
・     FIGURE 18          DEVELOPING MARKETS TO REGISTER HIGHER CAGR THAN DEVELOPED MARKETS THROUGHOUT FORECAST PERIOD

5      MARKET OVERVIEW

5.1             INTRODUCTION
5.2             MARKET DYNAMICS
・     FIGURE 19          IN VITRO TOXICOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1              MARKET DRIVERS
5.2.1.1            PUBLIC OPPOSITION TO ANIMAL TESTING
5.2.1.2            TECHNOLOGICAL ADVANCEMENTS IN TOXICOLOGY
5.2.1.3            R&D ON EARLY-STAGE TOXICITY DETECTION
5.2.2              MARKET RESTRAINTS   68
5.2.2.1            RELUCTANCE OF SOME REGULATORY AUTHORITIES TO ADOPT ALTERNATIVE TOXICOLOGY TESTING METHODS
5.2.2.2            FAILURE TO ESTABLISH INTRICACIES OF IN-VIVO CONDITIONS
5.2.2.3            LACK OF IN VITRO MODELS TO STUDY COMPLEX ENDPOINTS
5.2.3              MARKET OPPORTUNITIES
5.2.3.1            GROWING FOCUS ON DRUG DISCOVERY AND PERSONALIZED MEDICINE USING IN VITRO METHODS
5.2.3.2            INCREASING NUMBER OF TOXICOLOGY DATABASES
5.2.4              MARKET CHALLENGES   71
5.2.4.1            DEARTH OF SKILLED PROFESSIONALS IN TOXICITY TESTING

6      INDUSTRY INSIGHTS

6.1             INTRODUCTION
6.2             INDUSTRY TRENDS
6.2.1              INCREASING FOCUS ON PREDICTIVE TOXICOLOGY
6.3             SUPPLY CHAIN ANALYSIS
・     FIGURE 20          SUPPLY CHAIN ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET
6.4             REGULATORY COMMITTEE ACTIVITIES
6.4.1              MAJOR STAKEHOLDERS
6.4.2              KEY INFLUENCERS   74
6.5             COVID-19 IMPACT ON IN VITRO TOXICOLOGY MARKET
・     FIGURE 21          IMPACT OF COVID-19 ON IN VITRO TOXICOLOGY TESTING MARKET
6.6             PORTER’S FIVE FORCES ANALYSIS
・     TABLE 1              PORTER’S FIVE FORCES ANALYSIS
6.6.1              THREAT OF NEW ENTRANTS
6.6.2              THREAT OF SUBSTITUTES
6.6.3              BARGAINING POWER OF SUPPLIERS
6.6.4              DEGREE OF COMPETITIVE RIVALRY
6.7             TECHNOLOGY ANALYSIS

7      IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE

7.1             INTRODUCTION
7.2             COVID-19 IMPACT, BY PRODUCT & SERVICE
・     FIGURE 22          CONSUMABLES TO CAPTURE MAJORITY OF MARKET SHARE IN 2022
・     TABLE 2              IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE,
2019–2021 (USD MILLION)
・     TABLE 3              IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE,
2022–2027 (USD MILLION)
7.3             CONSUMABLES
7.3.1              CONSUMABLES TO ACCOUNT FOR LARGER MARKET SHARE THAN OTHER PRODUCTS IN 2022
・     TABLE 4              IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
・     TABLE 5              IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
7.4             ASSAYS
・     TABLE 6              ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY TYPE,
2019–2021 (USD MILLION)
・     TABLE 7              ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY TYPE,
2022–2027 (USD MILLION)
・     TABLE 8              ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2019–2021 (USD MILLION)
・     TABLE 9              ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2022–2027 (USD MILLION)
7.4.1              BACTERIAL TOXICITY ASSAYS
7.4.1.1            BACTERIAL ASSAYS TO CAPTURE LARGEST MARKET SHARE IN COMING YEARS OWING TO THEIR INCREASING ADOPTION ACROSS SEVERAL INDUSTRIES
・     TABLE 10            BACTERIAL TOXICITY ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2019–2021 (USD MILLION)
・     TABLE 11            BACTERIAL TOXICITY ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION)
7.4.2              ENZYME TOXICITY ASSAYS
7.4.2.1            ENZYME TOXICITY ASSAYS ARE INCREASINGLY USED IN ENDOCRINE-DISRUPTING STUDIES—MAJOR FACTOR DRIVING MARKET GROWTH
・     TABLE 12            ENZYME TOXICITY ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2019–2021 (USD MILLION)
・     TABLE 13            ENZYME TOXICITY ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION)
7.4.3              CELL-BASED ELISA & WESTERN BLOTS
7.4.3.1            CELL-BASED ASSAYS ARE COST-EFFECTIVE, THEREBY WITNESSING INCREASING ADOPTION IN DRUG DISCOVERY
・     TABLE 14            CELL-BASED ELISA & WESTERN BLOTS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
・     TABLE 15            CELL-BASED ELISA & WESTERN BLOTS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
7.4.4              RECEPTOR-BINDING ASSAYS
7.4.4.1            RECEPTOR-BINDING ASSAYS ARE SUI・     TABLE FOR HIGH-THROUGHPUT FORMATS, THEREBY EXHIBITING ACCELERATED DEMAND
・     TABLE 16            RECEPTOR-BINDING ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2019–2021 (USD MILLION)
・     TABLE 17            RECEPTOR-BINDING ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION)
7.4.5              TISSUE CULTURE ASSAYS
7.4.5.1            TISSUE CULTURE ASSAYS CAN MIMIC IN-VIVO TISSUE ARCHITECTURE, THEREBY ATTRACTING RESEARCHERS
・     TABLE 18            TISSUE CULTURE ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2019–2021 (USD MILLION)
・     TABLE 19            TISSUE CULTURE ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION)
7.4.6              OTHER ASSAYS
・     TABLE 20            OTHER ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
・     TABLE 21            OTHER ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
7.5             EQUIPMENT
7.5.1              FULLY AUTOMATED IN VITRO TOXICOLOGY EQUIPMENT ARE INCREASINGLY ADOPTED IN RESEARCH
・     TABLE 22            EQUIPMENT: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
・     TABLE 23            EQUIPMENT: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)

7.6             SOFTWARE
7.6.1              SOFTWARE SOLUTIONS ARE VITAL IN REDUCING ANALYSIS TIME AND MANAGING LARGE VOLUMES OF DATA GENERATED DURING OPERATIONS
・     TABLE 24            SOFTWARE: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2019–2021 (USD MILLION)
・     TABLE 25            SOFTWARE: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2022–2027 (USD MILLION)
7.7             SERVICES
7.7.1              LACK OF INFRASTRUCTURE AND EXPERTISE HAVE DRIVEN RELIANCE ON SERVICE PROVIDERS
・     TABLE 26            SERVICES: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2019–2021 (USD MILLION)
・     TABLE 27            SERVICES: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2022–2027 (USD MILLION)

8      IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST

8.1             INTRODUCTION
・     FIGURE 23          ORGAN TOXICITY TESTING TO REGISTER HIGHEST
CAGR DURING FORECAST PERIOD
・     TABLE 28            IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT &
TEST, 2019–2021 (USD MILLION)
・     TABLE 29            IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT &
TEST, 2022–2027 (USD MILLION)
8.2             ADME (ABSORPTION, DISTRIBUTION, METABOLISM, & EXCRETION)
8.2.1              ADME TESTING TO COMMAND IN VITRO TOXICOLOGY TESTING MARKET DURING FORECAST PERIOD
・     TABLE 30            ADME: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2019–2021 (USD MILLION)
・     TABLE 31            ADME: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2022–2027 (USD MILLION)
8.3             SKIN IRRITATION, CORROSION, & SENSITIZATION
8.3.1              SKIN IRRITATION, CORROSION, & SENSITIZATION ARE MAJOR ENDPOINTS STUDIED IN COSMETICS INDUSTRY
・     TABLE 32            SKIN IRRITATION, CORROSION, & SENSITIZATION: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
・     TABLE 33            SKIN IRRITATION, CORROSION, & SENSITIZATION: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
8.4             GENOTOXICITY
8.4.1              REGULATORY AUTHORITIES REVIEW AND VALIDATE HIGHER NUMBER OF GENOTOXICITY TESTS THAN ANY OTHER ENDPOINT, THEREBY PROPELLING MARKET GROWTH
・     TABLE 34            GENOTOXICITY: IN VITRO TOXICOLOGY TESTING, BY GEOGRAPHY,
2019–2021 (USD MILLION)
・     TABLE 35            GENOTOXICITY: IN VITRO TOXICOLOGY TESTING, BY GEOGRAPHY,
2022–2027 (USD MILLION)
8.5             CYTOTOXICITY
8.5.1              RISING NEED FOR BIOSAFETY LARGELY CONTRIBUTES TO GROWTH OF CYTOTOXICITY TESTING MARKET
・     TABLE 36            CYTOTOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
・     TABLE 37            CYTOTOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
8.6             OCULAR TOXICITY TESTING
8.6.1              IN VITRO AND EX-VIVO METHODS ARE GAINING HIGH RECOGNITION FOR OCULAR TOXICITY TESTING
・     TABLE 38            OCULAR TOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
・     TABLE 39            OCULAR TOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
8.7             ORGAN TOXICITY
8.7.1              HIGH-CONTENT SCREENING AND CELL-BASED ASSAYS ARE USED TO DETECT ORGAN-SPECIFIC TOXICITY
・     TABLE 40            ORGAN TOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
・     TABLE 41            ORGAN TOXICITY: TE IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION)
8.8             PHOTOTOXICITY
8.8.1              VALIDATED NON-ANIMAL METHODS ARE USED TO EVALUATE PHOTO SAFETY OF COSMETICS, PHARMACEUTICALS, & CHEMICALS
・     TABLE 42            PHOTOTOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
・     TABLE 43            PHOTOTOXICITY: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION)
8.9             DERMAL TOXICITY
8.9.1              IN VITRO METHODS FOR DERMAL TOXICITY TESTING ARE EXPECTED TO GAIN RECOGNITION IN COMING YEARS   119
・     TABLE 44            DERMAL TOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
・     TABLE 45            DERMAL TOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
8.10          OTHER ENDPOINTS & TESTS
・     TABLE 46            OTHER ENDPOINTS & TESTS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2019–2021 (USD MILLION)
・     TABLE 47            OTHER ENDPOINTS & TESTS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION)

9      IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY

9.1             INTRODUCTION
・     FIGURE 24          TOXICOGENOMICS SEGMENT TO EXHIBIT HIGHEST CAGR IN IN VITRO TOXICOLOGY TESTING MARKET DURING FORECAST PERIOD
・     TABLE 48            IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION)
・     TABLE 49            IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION)

9.2             CELL CULTURE
9.2.1              CELL- & TISSUE-BASED TECHNOLOGIES ARE WIDELY ADOPTED
IN IN VITRO TESTING
・     TABLE 50            CELL CULTURE: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
・     TABLE 51            CELL CULTURE: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
9.3             HIGH-THROUGHPUT
9.3.1              INCREASING USE OF HIGH-CONTENT IMAGING TECHNOLOGIES IN TOXICITY TESTING BOOSTS MARKET GROWTH
・     TABLE 52            HIGH-THROUGHPUT: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2019–2021 (USD MILLION)
・     TABLE 53            HIGH-THROUGHPUT: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION)
9.4             TOXICOGENOMICS
9.4.1              IMPROVEMENTS IN PROTEOMIC TECHNOLOGIES ENHANCE STUDY OF GENES & PROTEIN ACTIVITIES DURING TOXICITY ANALYSIS
・     TABLE 54            TOXICOGENOMICS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
・     TABLE 55            TOXICOGENOMICS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)

10   IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY

10.1          INTRODUCTION
・     FIGURE 25          PHARMACEUTICALS & BIOPHARMACEUTICALS INDUSTRY TO HOLD LARGEST MARKET SHARE THROUGHOUT FORECAST PERIOD   132
・     TABLE 56            IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION)
・     TABLE 57            IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION)
10.2          COVID-19 IMPACT, BY INDUSTRY
10.3          PHARMACEUTICALS & BIOPHARMACEUTICALS
10.3.1            DRUG ATTRITION RATE LEADS TO HIGH ADOPTION OF IN VITRO TESTING ASSAYS IN EARLY STAGES OF DRUG DEVELOPMENT
・     TABLE 58            PHARMACEUTICALS & BIOPHARMACEUTICALS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
・     TABLE 59            PHARMACEUTICALS & BIOPHARMACEUTICALS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
10.4          COSMETICS & HOUSEHOLD PRODUCTS
10.4.1            BAN ON ANIMAL TESTING LEADING TO ADOPTION OF IN VITRO ASSAYS FOR SAFETY TESTING
・     TABLE 60            COSMETICS & HOUSEHOLD PRODUCTS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
・     TABLE 61            COSMETICS & HOUSEHOLD PRODUCTS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
10.5          FOOD
10.5.1            INCREASING FOCUS ON FOOD SAFETY DRIVES REQUIREMENT FOR IN VITRO TOXICOLOGY TESTING PRODUCTS
・     TABLE 62            TYPES OF TOXICOLOGY TESTS IN FOOD
・     TABLE 63            FOOD: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2019–2021 (USD MILLION)
・     TABLE 64            FOOD: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2022–2027 (USD MILLION)
10.6          CHEMICALS
10.6.1            INCREASING FOCUS ON ORGANOID-BASED IN VITRO APPROACHES FOR CHEMICALS TESTING PROPELS MARKET GROWTH
・     TABLE 65            CHEMICALS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
・     TABLE 66            CHEMICALS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)

11   IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD

11.1          INTRODUCTION
・     FIGURE 26          IN-SILICO MODELS TO RECORD HIGHEST CAGR IN IN VITRO TOXICOLOGY TESTING MARKET DURING FORECAST PERIOD
・     TABLE 67            IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION)
・     TABLE 68            IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION)
11.2          CELLULAR ASSAYS
11.2.1            DEVELOPMENT OF MULTI-PARAMETER ASSAYS WILL PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES TO MARKET PLAYERS
・     TABLE 69            CELLULAR ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2019–2021 (USD MILLION)
・     TABLE 70            CELLULAR ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION)
11.3          BIOCHEMICAL ASSAYS
11.3.1            BIOCHEMICAL ASSAYS ARE ADOPTED AT HIGHER RATE IN PHARMACEUTICALS INDUSTRY THAN CHEMICALS AND FOOD INDUSTRIES
・     TABLE 71            BIOCHEMICAL ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2019–2021 (USD MILLION)
・     TABLE 72            BIOCHEMICAL ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION)
11.4          IN-SILICO MODELS
11.4.1            IN-SILICO MODELS ARE EXPECTED TO WITNESS HIGHEST CAGR
FROM 2022 TO 2027
・     TABLE 73            IN-SILICO MODELS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2019–2021 (USD MILLION)
・     TABLE 74            IN-SILICO MODELS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION)
11.5          EX-VIVO MODELS
11.5.1            EX-VIVO MODELS ARE WIDELY USED IN SKIN AND EYE TOXICOLOGY TESTING IN COSMETICS INDUSTRY
・     TABLE 75            EX-VIVO MODELS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
・     TABLE 76            EX-VIVO MODELS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)

12   IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHIC ANALYSIS

12.1          INTRODUCTION
12.2          COVID-19 IMPACT, BY REGION
・     FIGURE 27          IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC SNAPSHOT
・     TABLE 77            IN VITRO TOXICOLOGY TESTING MARKET, BY REGION,
2019–2021 (USD MILLION)
・     TABLE 78            IN VITRO TOXICOLOGY TESTING MARKET, BY REGION,
2022–2027 (USD MILLION)
12.3          EUROPE
・     FIGURE 28          EUROPE: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
・     TABLE 79            EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2019–2021 (USD MILLION)
・     TABLE 80            EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2022–2027 (USD MILLION)
・     TABLE 81            EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
・     TABLE 82            EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
・     TABLE 83            EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2019–2021 (USD MILLION)
・     TABLE 84            EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2022–2027 (USD MILLION)
・     TABLE 85            EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)
・     TABLE 86            EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)
・     TABLE 87            EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION)
・     TABLE 88            EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION)
・     TABLE 89            EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION)
・     TABLE 90            EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION)
・     TABLE 91            EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION)
・     TABLE 92            EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION)
12.3.1            GERMANY
12.3.1.1          GERMANY HOLDS THE LARGEST SHARE OF THE EUROPEAN MARKET
・     TABLE 93            GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
・     TABLE 94            GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
・     TABLE 95            GERMANY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2019–2021 (USD MILLION)
・     TABLE 96            GERMANY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2022–2027 (USD MILLION)
・     TABLE 97            GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)
・     TABLE 98            GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)
・     TABLE 99            GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION)
・     TABLE 100          GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION)
・     TABLE 101          GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION)
・     TABLE 102          GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION)
・     TABLE 103          GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION)
・     TABLE 104          GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION)
12.3.2            UK
12.3.2.1          RISING AWARENESS, GROWING R&D, AND INCREASING COLLABORATIONS
FOR IN VITRO TOXICOLOGY TESTING MARKET ARE KEY INDICATORS OF MARKET GROWTH IN UK
・     TABLE 105          UK: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
・     TABLE 106          UK: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
・     TABLE 107          UK: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2019–2021 (USD MILLION)
・     TABLE 108          UK: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2022-2027 (USD MILLION)
・     TABLE 109          UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)  175
・     TABLE 110          UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)  175
・     TABLE 111          UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION)
・     TABLE 112          UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION)
・     TABLE 113          UK: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION)
・     TABLE 114          UK: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION)
・     TABLE 115          UK: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION)
・     TABLE 116          UK: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION)
12.3.3            FRANCE
12.3.3.1          PROTEOMICS RESEARCH INITIATIVES SUPPORTED BY GOVERNMENT AID MARKET GROWTH IN FRANCE
・     TABLE 117          FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
・     TABLE 118          FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
・     TABLE 119          FRANCE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2019–2021 (USD MILLION)
・     TABLE 120          FRANCE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2022–2027 (USD MILLION)
・     TABLE 121          FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)  181
・     TABLE 122          FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)  181
・     TABLE 123          FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION)
・     TABLE 124          FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION)
・     TABLE 125          FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION)
・     TABLE 126          FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION)
・     TABLE 127          FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION)
・     TABLE 128          FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION)
12.3.4            ITALY
12.3.4.1          ITALIAN MARKET GROWTH IS MAINLY DRIVEN BY INCREASED VOLUME OF LIFE SCIENCES RESEARCH
・     TABLE 129          ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
・     TABLE 130          ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
・     TABLE 131          ITALY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2019–2021 (USD MILLION)
・     TABLE 132          ITALY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2022–2027 (USD MILLION)
・     TABLE 133          ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)  186
・     TABLE 134          ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)  187
・     TABLE 135          ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION)
・     TABLE 136          ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION)
・     TABLE 137          ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION)
・     TABLE 138          ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION)
・     TABLE 139          ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION)
・     TABLE 140          ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION)
12.3.5            SPAIN
12.3.5.1          SPAIN’S GROWING CHEMICALS INDUSTRY STIMULATES IN VITRO TOXICOLOGY TESTING MARKET GROWTH
・     TABLE 141          SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
・     TABLE 142          SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
・     TABLE 143          SPAIN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2019–2021 (USD MILLION)
・     TABLE 144          SPAIN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2022–2027 (USD MILLION)
・     TABLE 145          SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)  192
・     TABLE 146          SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)
・     TABLE 147          SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION)
・     TABLE 148          SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION)
・     TABLE 149          SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION)
・     TABLE 150          SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION)
・     TABLE 151          SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION)
・     TABLE 152          SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION)
12.3.6            REST OF EUROPE
・     TABLE 153          REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
・     TABLE 154          REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
・     TABLE 155          REST OF EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019–2021 (USD MILLION)
・     TABLE 156          REST OF EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022–2027 (USD MILLION)
・     TABLE 157          REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)
・     TABLE 158          REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)
・     TABLE 159          REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019–2021 (USD MILLION)
・     TABLE 160          REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2022–2027 (USD MILLION)
・     TABLE 161          REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019–2021 (USD MILLION)
・     TABLE 162          REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2022–2027 (USD MILLION)
・     TABLE 163          REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019–2021 (USD MILLION)
・     TABLE 164          REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2022–2027 (USD MILLION)
12.4          NORTH AMERICA
・     FIGURE 29          NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
・     TABLE 165          NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2019–2021 (USD MILLION)
・     TABLE 166          NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2022–2027 (USD MILLION)
・     TABLE 167          NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)

・     TABLE 168          NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
・     TABLE 169          NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019–2021 (USD MILLION)
・     TABLE 170          NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022–2027 (USD MILLION)
・     TABLE 171          NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)
・     TABLE 172          NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)
・     TABLE 173          NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019–2021 (USD MILLION)
・     TABLE 174          NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2022–2027 (USD MILLION)
・     TABLE 175          NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019–2021 (USD MILLION)
・     TABLE 176          NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2022–2027 (USD MILLION)
・     TABLE 177          NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019–2021 (USD MILLION)
・     TABLE 178          NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2022–2027 (USD MILLION)
12.4.1            US
12.4.1.1          US DOMINATES NORTH AMERICAN MARKET DUE TO GROWING FOCUS ON BIOMARKER DISCOVERY AND RESEARCH IN STRUCTURE-BASED DRUG DESIGN
・     TABLE 179          US: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
・     TABLE 180          US: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
・     TABLE 181          US: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2019–2021 (USD MILLION)
・     TABLE 182          US: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2022–2027 (USD MILLION)
・     TABLE 183          US: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)  211
・     TABLE 184          US: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)  211
・     TABLE 185          US: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION)
・     TABLE 186          US: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION)
・     TABLE 187          US: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION)
・     TABLE 188          US: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION)
・     TABLE 189          US: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION)
・     TABLE 190          US: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION)
12.4.2            CANADA
12.4.2.1          STRONG SUPPORT TO CARRY OUT R&D IN PHARMACEUTICAL AND PROTEOMICS FIELDS FOSTERS MARKET GROWTH IN CANADA
・     TABLE 191          CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
・     TABLE 192          CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
・     TABLE 193          CANADA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2019–2021 (USD MILLION)
・     TABLE 194          CANADA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2022–2027 (USD MILLION)
・     TABLE 195          CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)  217
・     TABLE 196          CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)  217
・     TABLE 197          CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION)
・     TABLE 198          CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION)
・     TABLE 199          CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION)
・     TABLE 200          CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION)
・     TABLE 201          CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION)
・     TABLE 202          CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION)
12.5          ASIA PACIFIC
・     FIGURE 30          ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
・     TABLE 203          ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2019–2021 (USD MILLION)
・     TABLE 204          ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2022–2027 (USD MILLION)
・     TABLE 205          ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
・     TABLE 206          ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
・     TABLE 207          ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019–2021 (USD MILLION)
・     TABLE 208          ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022–2027 (USD MILLION)
・     TABLE 209          ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)
・     TABLE 210          ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)
・     TABLE 211          ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019–2021 (USD MILLION)
・     TABLE 212          ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2022–2027 (USD MILLION)
・     TABLE 213          ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION)
・     TABLE 214          ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION)
・     TABLE 215          ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION)
・     TABLE 216          ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
 2022–2027 (USD MILLION)
12.5.1            CHINA
12.5.1.1          INCREASING INTERNATIONAL PRESSURE TO BAN ANIMAL TESTING METHODS WILL PROPEL MARKET GROWTH IN COMING YEARS
・     TABLE 217          CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
・     TABLE 218          CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
・     TABLE 219          CHINA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2019–2021 (USD MILLION)
・     TABLE 220          CHINA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2022–2027 (USD MILLION)
・     TABLE 221          CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)  231
・     TABLE 222          CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)  231
・     TABLE 223          CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION)
・     TABLE 224          CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
 2022–2027 (USD MILLION)
・     TABLE 225          CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION)
・     TABLE 226          CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION)
・     TABLE 227          CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION)
・     TABLE 228          CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION)
12.5.2            JAPAN
12.5.2.1          USE OF ARTIFICIAL SKIN PATCHES AND PLATES OF CULTURED HUMAN CELLS HAS INCREASED DEMAND FOR IN VITRO TOXICOLOGY TESTING PRODUCTS IN JAPAN
・     TABLE 229          JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
・     TABLE 230          JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
・     TABLE 231          JAPAN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2019–2021 (USD MILLION)
・     TABLE 232          JAPAN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2022–2027 (USD MILLION)
・     TABLE 233          JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)  237
・     TABLE 234          JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)  237
・     TABLE 235          JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION)
・     TABLE 236          JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION)
・     TABLE 237          JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
 2019–2021 (USD MILLION)
・     TABLE 238          JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION)
・     TABLE 239          JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION)
・     TABLE 240          JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION)
12.5.3            INDIA
12.5.3.1          GROWING FOCUS OF UNIVERSITIES ON AVOIDING USE OF ANIMALS TO TEST COSMETIC PRODUCTS IS LIKELY TO PROPEL MARKET GROWTH
・     TABLE 241          INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
・     TABLE 242          INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
・     TABLE 243          INDIA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2019–2021 (USD MILLION)
・     TABLE 244          INDIA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2022–2027 (USD MILLION)
・     TABLE 245          INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)  243
・     TABLE 246          INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)  243
・     TABLE 247          INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION)
・     TABLE 248          INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION)
・     TABLE 249          INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION)
・     TABLE 250          INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION)
・     TABLE 251          INDIA: IN VITRO TRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION)
・     TABLE 252          INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION)
12.5.4            REST OF ASIA PACIFIC
・     TABLE 253          REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
・     TABLE 254          REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
・     TABLE 255          REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET,
BY TYPE, 2019–2021 (USD MILLION)
・     TABLE 256          REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET,
BY TYPE, 2022–2027 (USD MILLION)
・     TABLE 257          REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET,
BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)
・     TABLE 258          REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET,
BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)
・     TABLE 259          REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET,
BY TECHNOLOGY, 2019–2021 (USD MILLION)
・     TABLE 260          REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET,
BY TECHNOLOGY, 2022–2027 (USD MILLION)
・     TABLE 261          REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET,
BY INDUSTRY, 2019–2021 (USD MILLION)
・     TABLE 262          REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET,
BY INDUSTRY, 2022–2027 (USD MILLION)
・     TABLE 263          REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET,
BY METHOD, 2019–2021 (USD MILLION)
・     TABLE 264          REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET,
BY METHOD, 2022–2027 (USD MILLION)
12.6          LATIN AMERICA
12.6.1            LOW COST OF DRUG TRIALS HAVE MADE LATIN AMERICA POPULAR OUTSOURCING MARKET
・     TABLE 265          LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
・     TABLE 266          LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
・     TABLE 267          LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019–2021 (USD MILLION)
・     TABLE 268          LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022–2027 (USD MILLION)
・     TABLE 269          LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)
・     TABLE 270          LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)

・     TABLE 271          LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019–2021 (USD MILLION)
・     TABLE 272          LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2022–2027 (USD MILLION)
・     TABLE 273          LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019–2021 (USD MILLION)
・     TABLE 274          LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2022–2027 (USD MILLION)
・     TABLE 275          LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019–2021 (USD MILLION)
・     TABLE 276          LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2022–2027 (USD MILLION)
12.7          MIDDLE EAST & AFRICA
12.7.1            INCREASING R&D INVESTMENTS AND FOCUS ON DEVELOPMENT OF NEW DRUGS ARE CONTRIBUTING TO MARKET GROWTH
・     TABLE 277          MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET,
BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
・     TABLE 278          MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET,
BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
・     TABLE 279          MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET,
BY TYPE, 2019–2021 (USD MILLION)
・     TABLE 280          MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET,
BY TYPE, 2022–2027 (USD MILLION)
・     TABLE 281          MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET,
BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)
・     TABLE 282          MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET,
BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)
・     TABLE 283          MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET,
BY TECHNOLOGY, 2019–2021 (USD MILLION)
・     TABLE 284          MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET,
BY TECHNOLOGY, 2022–2027 (USD MILLION)
・     TABLE 285          MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET,
BY INDUSTRY, 2019–2021 (USD MILLION)
・     TABLE 286          MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET,
BY INDUSTRY, 2022–2027 (USD MILLION)
・     TABLE 287          MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET,
BY METHOD, 2019–2021 (USD MILLION)
・     TABLE 288          MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET,
BY METHOD, 2022–2027 (USD MILLION)

13   COMPETITIVE LANDSCAPE

13.1          OVERVIEW
13.2          KEY PLAYER STRATEGIES/RIGHT TO WIN
・     FIGURE 31          KEY DEVELOPMENTS IN IN VITRO TOXICOLOGY TESTING MARKET,
2019–2022
13.3          MARKET SHARE ANALYSIS
・     FIGURE 32          IN VITRO TOXICOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2021
・     TABLE 289          IN VITRO TOXICOLOGY TESTING MARKET: DEGREE OF COMPETITION
13.4          REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
13.5          COMPANY EVALUATION QUADRANT
13.5.1            STAR
13.5.2            EMERGING LEADER
13.5.3            PERVASIVE
13.5.4            PARTICIPANT
・     FIGURE 34          IN VITRO TOXICOLOGY TESTING MARKET:
COMPANY EVALUATION QUADRANT, 2021
13.6          COMPANY EVALUATION QUADRANT: START-UPS/SMES
13.6.1            PROGRESSIVE COMPANY
13.6.2            STARTING BLOCK
13.6.3            RESPONSIVE COMPANY
13.6.4            DYNAMIC COMPANY
・     FIGURE 35          IN VITRO TOXICITY MARKET: COMPANY EVALUATION QUADRANT
FOR START-UPS/SMES, 2021
13.7          COMPANY FOOTPRINT ANALYSIS
13.7.1            COMPANY PRODUCT FOOTPRINT
・     TABLE 290          COMPANY PRODUCT FOOTPRINT: IN VITRO TOXICOLOGY
TESTING MARKET (2021)
13.8          COMPANY REGIONAL FOOTPRINT
・     TABLE 291          COMPANY REGIONAL FOOTPRINT: IN VITRO TOXICOLOGY
TESTING MARKET (2021)
13.9          COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
・     TABLE 292          IN VITRO TOXICOLOGY TESTING MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
・     TABLE 293          IN VITRO TOXICOLOGY TESTING MARKET: COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
13.10        COMPETITIVE SCENARIO
・     TABLE 294          PRODUCT LAUNCHES
・     TABLE 295          DEALS
・     TABLE 296          OTHER DEVELOPMENTS

14   COMPANY PROFILES

14.1          MAJOR PLAYERS
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS))*
14.1.1            THERMO FISHER SCIENTIFIC, INC.
・     TABLE 297          THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
・     FIGURE 36          THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021)
14.1.2            MERCK KGAA
・     TABLE 298          MERCK KGAA: BUSINESS OVERVIEW
・     FIGURE 37          MERCK KGAA: COMPANY SNAPSHOT (2021)
14.1.3            EUROFINS SCIENTIFIC SE
・     TABLE 299          EUROFINS SCIENTIFIC SE: BUSINESS OVERVIEW
・     FIGURE 38          EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2021)
14.1.4            GENERAL ELECTRIC COMPANY
・     TABLE 300          GENERAL ELECTRIC COMPANY: BUSINESS OVERVIEW
・     FIGURE 39          GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT (2021)
14.1.5            LABORATORY CORPORATION OF AMERICA HOLDINGS
・     TABLE 301          LABORATORY CORPORATION OF AMERICA HOLDINGS: BUSINESS OVERVIEW
・     FIGURE 40          LABORATORY CORPORATION OF AMERICA HOLDINGS:
COMPANY SNAPSHOT (2021)
14.1.6            CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
・     TABLE 302          CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: BUSINESS OVERVIEW
・     FIGURE 41          CHARLES RIVER LABORATORIES INTERNATIONAL, INC.:
COMPANY SNAPSHOT (2021)
14.1.7            SGS SA
・     TABLE 303          SGS SA: BUSINESS OVERVIEW
・     FIGURE 42          SGS SA: COMPANY SNAPSHOT (2021)
14.1.8            BIO-RAD LABORATORIES, INC.
・     TABLE 304          BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
・     FIGURE 43          BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021)
14.1.9            QIAGEN
・     TABLE 305          QIAGEN: BUSINESS OVERVIEW
・     FIGURE 44          QIAGEN: COMPANY SNAPSHOT (2021)
14.1.10         EVOTEC AG
・     TABLE 306          EVOTEC AG: BUSINESS OVERVIEW    327
・     FIGURE 45          EVOTEC AG: COMPANY SNAPSHOT (2021)
14.1.11         PROMEGA CORPORATION
・     TABLE 307          PROMEGA CORPORATION.: BUSINESS OVERVIEW
14.1.12         CATALENT, INC.
・     TABLE 308          CATALENT, INC.: BUSINESS OVERVIEW
・     FIGURE 46          CATALENT, INC.: COMPANY SNAPSHOT (2021)
14.2          OTHER COMPANIES
14.2.1            GENTRONIX LIMITED   337
・     TABLE 309          GENTRONIX LIMITED: COMPANY OVERVIEW
14.2.2            MB RESEARCH LABORATORIES
・     TABLE 310          MB RESEARCH LABORATORIES: COMPANY OVERVIEW
14.2.3            BIOIVT
・     TABLE 311          BIOIVT: COMPANY OVERVIEW
14.2.4            CREATIVE BIOLABS   340
・     TABLE 312          CREATIVE BIOLABS: COMPANY OVERVIEW
14.2.5            GVK BIOSCIENCES PRIVATE LIMITED
・     TABLE 313          GVK BIOSCIENCES PRIVATE LIMITED: COMPANY OVERVIEW
14.2.6            SHANGHAI MEDICILON INC.
・     TABLE 314          SHANGHAI MEDICILON INC.: COMPANY OVERVIEW
14.2.7            CREATIVE BIOARRAY  343
・     TABLE 315          CREATIVE BIOARRAY: COMPANY OVERVIEW
14.2.8            INSPHERO
・     TABLE 316          INSPHERO: COMPANY OVERVIEW    344
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS) MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.

15   RELATED MARKETS

15.1          INTRODUCTION
15.2          IN VIVO TOXICITY MARKET
15.2.1            MARKET DEFINITION   345
15.2.2            LIMITATIONS
15.2.3            MARKET OVERVIEW    345
・     FIGURE 47          CONSUMABLES SEGMENT WILL CONTINUE TO DOMINATE THE IN VIVO TOXICOLOGY MARKET DURING THE FORECAST PERIOD
15.3          IN VIVO TOXICOLOGY MARKET, BY PRODUCT
15.3.1            CONSUMABLES
・     TABLE 317          IN VIVO TOXICITY CONSUMABLES MARKET, BY COUNTRY/REGION,
2015–2022 (USD MILLION)
15.3.2            INSTRUMENTS
・     TABLE 318          IN VIVO TOXICOLOGY INSTRUMENTS MARKET, BY COUNTRY/REGION,
2015–2022 (USD MILLION)
15.4          IN VIVO TOXICITY MARKET, BY TOXICITY ENDPOINT
15.4.1            IMMUNOTOXICITY
・     TABLE 319          IN VIVO TOXICOLOGY MARKET FOR IMMUNOTOXICITY, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
15.4.2            SYSTEMIC TOXICITY  351
・     TABLE 320          IN VIVO TOXICOLOGY MARKET FOR SYSTEMIC TOXICITY,
BY COUNTRY/REGION, 2015–2022 (USD MILLION)
15.4.3            CARCINOGENICITY  352
・     TABLE 321          IN VIVO TOXICOLOGY MARKET FOR CARCINOGENICITY,
BY COUNTRY/REGION, 2015–2022 (USD MILLION)
15.4.4            GENOTOXICITY
・     TABLE 322          IN VIVO TOXICOLOGY MARKET FOR GENOTOXICITY, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
15.4.5            DEVELOPMENTAL AND REPRODUCTIVE TOXICITY (DART)
・     TABLE 323          IN VIVO TOXICOLOGY MARKET FOR DEVELOPMENTAL AND REPRODUCTIVE TOXICITY, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
15.4.6            OTHER TOXICITY ENDPOINTS
・     TABLE 324          IN VIVO TOXICOLOGY MARKET FOR OTHER TOXICITY ENDPOINTS,
BY COUNTRY/REGION, 2015–2022 (USD MILLION)
15.5          IN VIVO TOXICITY MARKET, BY REGION
15.5.1            NORTH AMERICA
・     TABLE 325          NORTH AMERICA: IN VIVO TOXICOLOGY MARKET, BY TOXICOLOGY ENDPOINT, 2015–2022 (USD MILLION)
15.5.2            EUROPE
・     TABLE 326          EUROPE: IN VIVO TOXICOLOGY MARKET, BY TOXICOLOGY ENDPOINT,
2015–2022 (USD MILLION)
15.5.3            ASIA PACIFICASIA PACIFIC
・     TABLE 327          ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET, BY TOXICOLOGY ENDPOINT, 2015–2022 (USD MILLION)
15.5.4            LATIN AMERICA
・     TABLE 328          LATIN AMERICA: IN VIVO TOXICOLOGY MARKET, BY TOXICOLOGY ENDPOINT, 2015–2022 (USD MILLION)
15.5.5            MIDDLE EAST & AFRICA
・     TABLE 329          MIDDLE EAST & AFRICA: IN VIVO TOXICOLOGY MARKET, BY TOXICOLOGY ENDPOINT, 2015–2022 (USD MILLION)  359

16   APPENDIX

16.1          INSIGHTS OF INDUSTRY EXPERTS
16.2          DISCUSSION GUIDE
16.3          KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.4          AVAILABLE CUSTOMIZATIONS
16.5          RELATED REPORTS
16.6          AUTHOR DETAILS

△ 一番上に戻る